Get the Stockscreener App
13.79
2.53%
0.34
Inmode Ltd stock is traded at $13.79, with a volume of 2.24M.
It is up +2.53% in the last 24 hours and down -8.65% over the past month.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.
See More
Previous Close:
$13.45
Open:
$13.39
24h Volume:
2.24M
Relative Volume:
2.23
Market Cap:
$873.72M
Revenue:
$370.50M
Net Income/Loss:
$93.83M
P/E Ratio:
9.5347
EPS:
1.4463
Net Cash Flow:
$89.39M
1W Performance:
+8.07%
1M Performance:
-8.65%
6M Performance:
-6.19%
1Y Performance:
-26.06%
1-Day Range:
$13.39
$13.80
1-Week Range:
$13.32
$13.86
52-Week Range:
$12.72
$19.09
Inmode Ltd Stock (INMD) Company Profile
Compare INMD vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INMD
Inmode Ltd
|
13.79 | 873.72M | 370.50M | 93.83M | 89.39M | 1.4463 |
ABT
Abbott Laboratories
|
107.19 | 186.26B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
339.76 | 130.02B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.87 | 111.53B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
69.89 | 103.71B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
82.46 | 47.89B | 6.07B | 1.06B | 1.34B | 1.8063 |
Inmode Ltd Stock (INMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-29-25 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-28-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-17-24 | Initiated | BTIG Research | Buy |
| Jul-23-24 | Downgrade | Jefferies | Buy → Hold |
| Nov-03-23 | Downgrade | UBS | Buy → Neutral |
| Oct-13-23 | Downgrade | Canaccord Genuity | Buy → Hold |
| Mar-29-23 | Initiated | UBS | Buy |
| Feb-17-23 | Downgrade | Needham | Buy → Hold |
| Dec-21-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| May-25-21 | Initiated | Barclays | Overweight |
| May-18-21 | Initiated | Needham | Buy |
| Sep-03-19 | Initiated | Barclays | Overweight |
| Sep-03-19 | Initiated | Canaccord Genuity | Buy |
| Sep-03-19 | Initiated | Robert W. Baird | Outperform |
| Sep-03-19 | Initiated | UBS | Buy |
View All
Inmode Ltd Stock (INMD) Latest News
(INMD) Movement as an Input in Quant Signal Sets - Stock Traders Daily
InMode Ltd. (NASDAQ:INMD) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Do Options Traders Know Something About InMode Stock We Don't? - MSN
InMode Ltd Stock (ISIN: IL0011356806) Faces Headwinds Amid Medtech Sector Slowdown and Revenue Press - AD HOC NEWS
InMode CFO Sees Demand Stabilizing, Targets Flat 2026 Revenue as North America Rebuild Begins - MarketBeat
InMode Details Israel Disruptions, 60% Capacity and $600M Buyback Plans at Oppenheimer Conference - Yahoo Finance
InMode Ltd. (NASDAQ: INMD) Q4 2025 earnings call transcript - MSN
InMode (INMD) director Michael Anghel details initial share and RSU stake - Stock Titan
InMode (INMD) CEO Moshe Mizrahy discloses 4,299,226 ordinary shares in Form 3 - Stock Titan
InMode (INMD) director Kenneth Nadav discloses initial share and RSU stake - Stock Titan
InMode (INMD) CTO Michael Kreindel discloses 3.1M-share insider stake - Stock Titan
InMode (INMD) CFO discloses shares, options and RSUs in Form 3 - Stock Titan
InMode (INMD) North America president reports ordinary share and RSU holdings - Stock Titan
InMode (INMD) director Ron Hadar reports Form 3 share holdings - Stock Titan
InMode sets new share repurchase program - MSN
InMode at Oppenheimer Conference: Strategic Shifts Amid Challenges By Investing.com - Investing.com Canada
InMode at Oppenheimer Conference: Strategic Shifts Amid Challenges - Investing.com
Short Interest in InMode Ltd. (NASDAQ:INMD) Decreases By 14.9% - MarketBeat
InMode announces new share repurchase program - Medical Buyer
Doma Perpetual Capital Management LLC Has $42.29 Million Position in InMode Ltd. $INMD - MarketBeat
956,630 Shares in InMode Ltd. $INMD Purchased by Ancient Art L.P. - MarketBeat
How InMode’s New 10% Share Buyback Plan Will Impact InMode (INMD) Investors - Yahoo Finance
InMode Shares Gain After Preliminary Q3 Revenue Beats Expectations - MSN
InMode Board Approves Buyback Covering Nearly 10% Of Stock - Sahm
InMode (INMD) Valuation Check As New US$ Share Buyback Targets Around 10% Of Outstanding Stock - simplywall.st
Topline Capital Management LLC Has $3.95 Million Stock Holdings in InMode Ltd. $INMD - MarketBeat
InMode authorizes share buyback of up to 6.38 million shares By Investing.com - Investing.com India
InMode authorizes share buyback of up to 6.38 million shares - Investing.com Australia
InMode stock jumps after new buyback program announced By Investing.com - Investing.com South Africa
InMode stock jumps after new buyback program announced - Investing.com India
InMode (NASDAQ:INMD) Shares Gap UpShould You Buy? - MarketBeat
InMode Ltd. authorizes a Buyback Plan. - marketscreener.com
Why Is InMode Stock Surging Friday?InMode (NASDAQ:INMD) - Benzinga
InMode Ltd. announces an Equity Buyback for 6,380,000 shares, representing 10% of its issued share capital. - marketscreener.com
InMode Authorizes New Share Repurchase Program Covering Up to 10% of Shares - TipRanks
InMode (Nasdaq: INMD) authorizes new buyback for about 10% of shares - Stock Titan
InMode Announces New Share Repurchase Program - Financial Times
Resistance Check: Is InMode Ltd likely to announce a buybackQuarterly Investment Review & Risk Managed Trade Strategies - baoquankhu1.vn
InMode wins case against DHGate sellers over counterfeit products - MSN
InMode at Barclays Healthcare Conference: Strategic Expansion Amid Challenges By Investing.com - Investing.com South Africa
InMode at Barclays Healthcare Conference: Strategic Expansion Amid Challenges - Investing.com India
InMode Ltd. Stock Plummets to New 52-Week Low at $12.95 - Markets Mojo
InMode Ltd. Forms Death Cross, Signaling Potential Bearish Trend Ahead - Markets Mojo
Moshe Mizrahy reports 6.23% InMode (INMD) ownership stake - Stock Titan
InMode (NASDAQ:INMD) Sets New 1-Year LowHere's What Happened - MarketBeat
Liquidity Mapping Around (INMD) Price Events - Stock Traders Daily
JPMorgan Chase & Co. Sells 198,293 Shares of InMode Ltd. $INMD - MarketBeat
Profit Recap: Whats next for InMode Ltd stockEarnings Risk Summary & Capital Efficient Trade Techniques - baoquankhu1.vn
Treasury Yields: Is InMode Ltd a top pick in the sector2025 Top Decliners & AI Based Buy/Sell Signal Reports - baoquankhu1.vn
Institution Moves: Will InMode Ltd benefit from rising consumer demandDay Trade & Real-Time Market Sentiment Alerts - baoquankhu1.vn
Update Report: Is InMode Ltd a top pick in the sectorJuly 2025 Setups & Smart Swing Trading Alerts - baoquankhu1.vn
Inmode Ltd Stock (INMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.85%
1.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):